Streptococcus pneumoniae serotype (S. pneumoniae serotype (no widely used standard abbreviation for all serotypes collectively; individual serotypes are often abbreviated, e.g., "S. pneumoniae 19F"))

Streptococcus pneumoniae is a Gram-positive bacterium responsible for diseases such as pneumonia, meningitis, and sepsis. Its primary virulence factor is the **polysaccharide capsule**, which surrounds the bacterial cell wall and enables it to evade host immune responses by inhibiting phagocytosis[7]. The chemical structure of this capsule varies among strains—these variations define more than 100 known **serotypes** or "capsular types"[5][7]. Each serotype differs in its prevalence, invasiveness, drug resistance profile, and ability to cause disease. Serotyping is crucial for epidemiology and vaccine design because immunity to one capsular type does not necessarily confer protection against others. Vaccines like PCV13 target the most common or invasive serotypes but do not cover all existing types; non-vaccine types can become more prevalent after widespread vaccination—a phenomenon called **serotype replacement**[1][4]. Some pneumococcal diseases are associated with specific high-risk or multidrug-resistant serotypes such as 19F, 6A/B, 23F, and emerging non-vaccine types like 24F[1][2][4]. Diagnostic laboratories use PCR-based methods targeting genes involved in capsule synthesis to identify both S. pneumoniae species and their specific **serotypes** for surveillance purposes[5]. The term “Streptococcus pneumoniae serotypes” refers collectively to a group of structurally distinct surface antigens rather than a single molecular entity or receptor typically considered a therapeutic target. While these capsules are direct targets for vaccines—and thus relevant as immunological/therapeutic targets—they do not represent a single molecule but rather over one hundred different variants defined by their unique carbohydrate structures. Therefore, *is_incorrect* is set to true because this entry refers broadly to many related but distinct molecular entities rather than one canonical molecule/receptor suitable for structured database representation under typical drug-target conventions.[5][7]

Other names

Pneumococcal serotypePneumococcus capsular typeS. pneumoniae capsular polysaccharide type

Induction of immune response via recognition of specific capsular polysaccharides by antibodies and immune cells[5][7]